RhumbLine Advisers
GLSI icon

RhumbLine Advisers’s Greenwich LifeSciences GLSI Stock Holding History

RhumbLine Advisers’s Portfolio GLSI Stock Details GLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$197K Buy
8,387
+341
+4% +$8.3K ﹤0.01% 3289
2026
Q1 		$193K Sell
8,046
-40
-0.5% -$1.04K ﹤0.01% 3136
2025
Q4 		$170K Sell
8,086
-1,081
-12% -$11.4K ﹤0.01% 3252
2025
Q3 		$91.2K Buy
9,167
+192
+2% +$2.17K ﹤0.01% 3546
2025
Q2 		$81.4K Sell
8,975
-698
-7% -$6.64K ﹤0.01% 3586
2025
Q1 		$92.3K Buy
9,673
+3,168
+49% +$38.4K ﹤0.01% 3413
2024
Q4 		$73K Buy
6,505
+203
+3% +$2.72K ﹤0.01% 3560
2024
Q3 		$90.6K Sell
6,302
-497
-7% -$7.36K ﹤0.01% 3525
2024
Q2 		$117K Buy
+6,799
New +$99.3K ﹤0.01% 3469

Other funds holding GLSI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

RhumbLine Advisers's GLSI Position: Q2 2026 in Review

RhumbLine Advisers increased its Greenwich LifeSciences (GLSI) stake by 4.2% in Q2 2026, buying an estimated $8.3K and bringing the position to 8,387 shares worth $197K. The position accounts for ﹤0.01% of the portfolio, ranked #3289.

RhumbLine Advisers first reported a position in GLSI in Q2 2024 and has held it in 9 quarters since. 58 funds tracked by Wall St. Rank hold GLSI as of Q2 2026.

  • RhumbLine Advisers held 8,387 shares of Greenwich LifeSciences worth $197K as of Q2 2026.
  • RhumbLine Advisers bought 341 Greenwich LifeSciences shares in Q2 2026, an estimated $8.3K.
  • Greenwich LifeSciences made up ﹤0.01% of RhumbLine Advisers's portfolio in Q2 2026, its #3289 holding.
  • RhumbLine Advisers first reported a position in Greenwich LifeSciences in Q2 2024 and has held it in 9 quarters since.
  • 58 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q2 2026.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.